Eastman Chemical financials
$65.75−1.08%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.51B | $2.18B | $1.97B | $2.20B | $2.29B | $2.29B | $2.25B | $2.46B | $2.36B | $2.31B | $2.21B | $2.27B |
| Gross profit | $560.0M | $431.0M | $338.0M | $433.0M | $506.0M | $567.0M | $554.0M | $605.0M | $599.0M | $532.0M | $464.0M | $484.0M |
| Gross margin | 22.3% | 19.8% | 17.1% | 19.7% | 22.1% | 24.8% | 24.7% | 24.6% | 25.3% | 23.0% | 21.0% | 21.3% |
| Operating income | $309.0M | $201.0M | $88.0M | $191.0M | $269.0M | $310.0M | $354.0M | $332.0M | $359.0M | $276.0M | $152.0M | $266.0M |
| Net income | $183.0M | $107.0M | $105.0M | $47.0M | $140.0M | $182.0M | $330.0M | $180.0M | $230.0M | $165.0M | $310.0M | $178.0M |
| Net margin | 7.3% | 4.9% | 5.3% | 2.1% | 6.1% | 7.9% | 14.7% | 7.3% | 9.7% | 7.1% | 14.0% | 7.9% |
| Diluted EPS | $1.59 | $0.93 | $0.92 | $0.40 | $1.20 | $1.57 | $2.82 | $1.53 | $1.94 | $1.39 | $2.60 | $1.49 |
| EBITDA | $442.0M | $341.0M | $273.0M | $340.0M | $409.0M | $445.0M | $493.0M | $489.0M | $485.0M | $414.0M | $167.0M | $386.0M |
| Operating cash flow | $224.0M | -$137.0M | $502.0M | $402.0M | $233.0M | -$167.0M | $540.0M | $396.0M | $367.0M | -$16.0M | $452.0M | $514.0M |
| Free cash flow | $124.0M | -$240.0M | $390.0M | $265.0M | $83.0M | -$314.0M | $361.0M | $276.0M | $252.0M | -$201.0M | $277.0M | $278.0M |
| Diluted shares | 115.3M | 115.0M | 114.3M | 115.4M | 116.2M | 116.5M | 117.0M | 117.8M | 118.6M | 118.2M | 119.3M | 119.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $691.0M | $665.0M | $566.0M | $489.0M | $423.0M | $418.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $5.22B | $5.22B | $4.79B | $5.08B | $5.13B | $5.02B |
| Total assets | $15.42B | $15.22B | $14.86B | $14.98B | $15.22B | $14.97B |
| Total liabilities | $9.25B | $9.14B | $8.82B | $9.14B | $9.31B | $9.03B |
| Shareholders' equity | $6.17B | $6.09B | $6.04B | $5.84B | $5.91B | $5.94B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology